Locagel

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Locagel

Property Description
Active Ingredient Diclofenac (as Diclofenac Diethylamine)
Form Gel (Topical preparation)
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common Use Localized relief of pain and inflammation
Origin Synthetic (Phenylacetic acid derivative)

What Type of Medicine is Locagel? (Classification and Identity)

Locagel is a specialized topical pharmaceutical preparation whose active substance, Diclofenac, classifies it as a Nonsteroidal Anti-Inflammatory Drug (NSAID), belonging to the phenylacetic acid chemical class. This medicine is a synthetic, single-ingredient product designed exclusively for external application. The classification as an NSAID is officially recognized under the ATC code M02AA15, which groups it with anti-inflammatory preparations for topical use.

This established pharmaceutical identity, clinically recognized for its localized anti-inflammatory activity, distinguishes it from non-medicinal topical agents or systemic NSAID formulations. Locagel is commonly available for over-the-counter (OTC) use in various regions, indicating its established safety profile for targeted symptomatic relief. The medicine is engineered to address symptomatic discomfort associated with the locomotor apparatus, such as minor strains or contusions.

Locagel’s Composition and Pharmaceutical Form (Ingredients and Presentation)

The sole active ingredient in Locagel is Diclofenac, typically incorporated as the salt Diclofenac diethylamine to facilitate better penetration through the skin barrier. The product is physically presented in the dosage form of a gel (or emulgel), which utilizes an aqueous or hydro-alcoholic emulsion base. This specific composition and physical form dictate its topical route of administration.

The gel formulation ensures that the active substance is delivered locally to the underlying tissues, concentrating its action where it is needed most. This topical route of administration is designed to deliver pain relief directly to the affected area with reduced systemic exposure.

What is the General Purpose of Locagel? (Action and Benefit)

The general purpose of Locagel is to provide localized relief by exerting both an anti-inflammatory effect and an analgesic effect at the site of application. It achieves this general therapeutic benefit by acting as an inhibitor of the biochemical pathways responsible for generating pain and inflammation.

The NSAID class works by reducing the inflammation which is often the source of localized pain. Consequently, the primary benefit is to alleviate swelling and its associated pain directly at the application site.

Regulatory References

  1. Diclofenac: MedlinePlus Drug Information
  2. Diclofenac - StatPearls - NCBI Bookshelf

What side effects are possible with Locagel?

Possible Side Effects and Safety Information

The official safety profile for Locagel (Diclofenac Diethylamine gel), a topical Nonsteroidal Anti-Inflammatory Drug (NSAID), is based on regulatory documentation classifying adverse reactions primarily by frequency and the body system affected.


Classification of Documented Adverse Reactions

The most frequent documented adverse reactions are localized to the Skin and Subcutaneous Tissue and are considered Common (up to 1 in 10 individuals). These typically include dermatitis, rash, eczema, erythema, and pruritus (itching).

Less frequent, or Rare and Very Rare, adverse events are also documented and relate to the potential for systemic absorption of the NSAID. These include bullous dermatitis, severe cutaneous reactions like Stevens-Johnson Syndrome, and systemic reactions such as asthma in susceptible patients.


Systemic and Population Safety Constraints

While systemic exposure is low, regulatory information formally includes the potential for rare systemic NSAID effects, such as gastrointestinal ulceration or renal impairment. The risk of such systemic effects is stated to increase with the duration of treatment and the area of skin over which the product is applied.

Official labeling includes specific constraints for certain populations. The product is not recommended for use in individuals with severe renal or hepatic impairment. Furthermore, patients with a history of allergic reactions (e.g., asthma, urticaria) to aspirin or other NSAIDs are identified as having a specific susceptibility to certain reactions.

Overdose and Emergency Response

Overdose and When to Seek Help

The risk of severe systemic overdose from the correct topical application of Locagel (diclofenac diethylamine gel) is considered low due to the limited absorption through the skin, as documented in regulatory information. However, the official overdose profile addresses scenarios involving the accidental ingestion of a large quantity of the gel, which can result in systemic effects.

Documented Manifestations and Actions

Overdose Domain Official Regulatory Statement
Symptom Presentations Manifestations may mirror systemic NSAID toxicity, including gastrointestinal disorders (e.g., nausea, vomiting, abdominal pain) and Central Nervous System effects (e.g., headache, dizziness, somnolence).
Severe Outcomes Significant systemic overexposure poses a risk of serious organ complications, including acute renal failure, hepatic damage, and convulsions, as documented in regulatory labeling.
Emergency Action Required Immediate medical attention is required in the event of accidental ingestion of the gel. Treatment is strictly symptomatic and supportive, and no specific antidote is known.
Monitoring Hospital monitoring of vital functions and renal and hepatic status is required for suspected systemic toxicity.

If systemic overexposure is confirmed, the management focuses on supportive care, consistent with official regulatory instructions. Patients with pre-existing impaired renal or hepatic function are noted in labeling as potentially being at a greater risk of renal injury following such exposure.

Therapeutic Uses of Locagel

What Locagel Treats: Main Uses and Benefits

Locagel (Diclofenac Diethylamine gel) is commonly used to provide supportive relief in conditions where symptoms create noticeable physiological strain. The medication is utilized to help with both short-term discomfort and the ongoing management of localized symptomatic burden, specifically for the management of localized pain and inflammation.


Targeted Symptomatic Relief

The gel is relevant when supportive symptom management is appropriate for symptoms associated with acute or episodic changes, such as those related to physical discomfort. It is applied across domains where short-term symptomatic assistance is needed for symptoms linked to soft tissue discomfort. It is also considered relevant in conditions characterized by periods of heightened symptoms, such as those associated with chronic joint discomfort or symptoms related to structures around the joints.

This supportive relief contributes to easing the overall symptom load and helps improve day-to-day comfort.

“Applied in contexts where additional symptomatic support is needed, the medicine assists with easing localized symptoms that interfere with daily functioning.”


Key Therapeutic Contexts

Quick Fact: Relief for Localized Pain and Swelling

The medication is commonly used to help with symptoms related to physical discomfort, such as pain, swelling, and stiffness, associated with:

  1. Acute soft tissue injuries (strains, sprains, and contusions).
  2. Chronic joint conditions (localized discomfort from osteoarthritis).
  3. Periarticular inflammation (tendonitis and bursitis).

This targeted approach provides supportive relief when symptoms become more noticeable, helping patients cope more steadily with symptom fluctuations.

Eligibility and Restrictions for Use

Who Can and Cannot Use Locagel?

Eligibility for using Locagel (Diclofenac Diethylamine gel) is strictly determined by official regulatory criteria, primarily based on contraindications related to its Nonsteroidal Anti-Inflammatory Drug (NSAID) class and specific patient characteristics. The medicine is generally intended for use by adults and adolescents aged 14 years and older.

Populations and Conditions that Define Non-Eligibility

Classification Population/Condition
Absolute Contraindication Known hypersensitivity to diclofenac, aspirin, or any other NSAID.
Absolute Contraindication Individuals who have experienced asthma, urticaria, or acute rhinitis after taking aspirin or an NSAID.
Absolute Contraindication Women in the third trimester of pregnancy.
Age Restriction Children under 14 years of age (use not recommended or established).
Application Restriction Application on broken skin, open wounds, mucous membranes, or near the eyes is prohibited.

Restricted or Conditional Use

Use is not recommended for women in the first or second trimesters of pregnancy or while breastfeeding. Caution is advised for patients with existing severe hepatic or renal impairment, and those with a history of gastrointestinal bleeding or cardiac dysfunction, due to the theoretical risk of systemic NSAID effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Locagel (Topical Diclofenac) details interactions primarily related to its Nonsteroidal Anti-Inflammatory Drug (NSAID) classification, despite limited systemic absorption.


Contraindications and Restrictions

Use of the gel is contraindicated in the setting of perioperative pain related to Coronary Artery Bypass Graft (CABG) surgery. Concomitant use with other oral NSAIDs is not generally recommended and should be avoided due to the potential for increased systemic adverse effects.


Clinically Significant Interactions

The regulatory labeling documents several pharmacodynamic interactions:

  • Hemostasis-Modifying Drugs: Combining the gel with medicines that affect blood clotting, such as anticoagulants (e.g., warfarin) or antiplatelet agents (e.g., aspirin), increases the risk of serious bleeding events.
  • Antihypertensives and Diuretics: Diclofenac may reduce the efficacy of blood pressure medicines, including ACE Inhibitors and ARBs, and diminish the natriuretic effect of diuretics.
  • Exposure: Co-administration may increase the serum concentration and prolong the half-life of Digoxin.
  • Alcohol: Consumption of alcohol is officially associated with an increased risk of gastrointestinal adverse events when used with NSAIDs.

Procedural and Population Notes

A procedural constraint requires patients to wait at least one hour before washing their hands if the hands are the site of treatment. An interaction note warns that co-administration of ACE Inhibitors or ARBs in elderly, volume depleted, or renally impaired patients carries a heightened risk of deterioration of renal function.

Mechanism of Action

Enzyme Target and Mechanism of Action

Locagel's primary mechanism involves the active ingredient, diclofenac, functioning as a non-selective competitive inhibitor of the Cyclooxygenase (COX) enzymes. Blocking these enzymes is the initiating step in the mechanistic cascade, directly suppressing the biosynthesis of key lipid mediators, specifically prostaglandins. This action is localized due to the drug's delivery via a topical gel, allowing targeted accumulation in the underlying tissues.


Pathways and Physiological Modulation

This molecular interaction directly interferes with the Arachidonic Acid Cascade, thereby limiting the production of prostaglandins that promote local inflammation. By modifying the concentration of these chemical signals, Locagel alters the excitability of peripheral pain receptors (nociceptors), resulting in the localized modulation of pain signal transmission. This mechanism is predominantly peripheral, focusing the biological consequences on local tissues and leading to a reduction of localized tissue swelling and excessive mediator activity.

Dosage and Administration Information

Administration Instructions for Locagel (Diclofenac Topical Solution)

Locagel is administered topically to the skin, typically for use on the knee(s). Adherence to the specified procedure is essential for proper dosing and use.

Administration Scope Detail
Route of Administration Topical (Local cutaneous application).
Dosing Schedule 2 pump actuations on each painful knee, applied 2 times a day. The prescribed dose is 40 mg per knee per application.
Frequency Pattern Twice-daily application.
Timing in Relation to Meals Not applicable (Topical administration).

Procedural Steps and Special Conditions

Before application, ensure the skin on the knee is clean and dry. The pump mechanism must be primed before the first use by fully depressing the pump four times and discarding this initial volume.

Application Sequence:

  1. Dispense the dose (2 pump actuations) directly onto the knee or first into the hand.
  2. Spread the product evenly around the front, back, and sides of the knee.
  3. Wash hands completely immediately after administering the product, unless the hands are the treated joint.
  4. Wait until the treated area is completely dry before covering with clothing or applying other topical substances (e.g., sunscreen, cosmetics, other medications).

Mandatory Safety Conditions:

  • Avoid contact with eyes and mucous membranes.
  • Do not apply external heat or occlusive dressings to the treated area.
  • Protect the treated knee(s) from natural and artificial sunlight; wear covering clothing if sun exposure is anticipated.
  • Avoid skin-to-skin contact with others until the treated area is completely dry.

Recent Clinical Evidence

Locagel: Recent Clinical Evidence

Scope and Focus of Investigation

Research has explored the clinical profile of the active ingredient in Locagel, topical diclofenac, across various musculoskeletal conditions, including osteoarthritis, sprains, and localized soft tissue pain. The research protocol for these investigations focused on monitoring specific molecular markers related to pain and inflammation at the application site.


Key Findings on Outcomes Studied

Studies consistently examined the measurement of pain severity scores compared to a non-active gel or placebo, predominantly in conditions like acute sprains and localized rheumatic pain. Specific trials also evaluated the measurement of changes in mobility scores and functional capacity over periods typically ranging from one to four weeks. Findings from these trials have documented a difference in scores compared to placebo in many subjects. One specific Phase 2 trial assessed a combination formulation of diclofenac with an older compound, where the results regarding efficacy were noted as mixed.


Systemic Exposure and Safety Profile

Clinical studies have established that the systemic absorption (the amount of drug that enters the bloodstream) of topical diclofenac is substantially lower than that observed with oral forms of the same drug. This low systemic exposure is a primary feature monitored in the safety profile of the topical formulation.

In studies collecting long-term data on adverse events, the most frequently reported events were local skin reactions at the site of application, such as dry skin, crusting, or rash. The incidence of serious systemic adverse events commonly associated with oral non-steroidal anti-inflammatory drugs (NSAIDs) was observed to be rare or comparable to placebo in the trials. These findings outline the scope of the studies that evaluated the topical drug for its approved indications. Research remains ongoing.

Frequently Asked Questions (FAQ)

Common questions about Locagel (FAQ)


Q: How quickly should I expect Locagel to start working?

Official studies on topical diclofenac, the active ingredient in Locagel, often measure changes in pain and functional scores over evaluation periods ranging from one to four weeks or longer. These studies indicate that the product is intended for localized relief that develops over time, and it is not generally considered for immediate pain relief.

Q: What is the typical duration of the effect after applying Locagel?

The product’s official regulatory dosing schedule describes application two times a day, typically in the morning and evening. This dosing frequency is established to maintain the intended localized therapeutic effect throughout the day.

Q: Are there any major safety warnings for Locagel I should know about?

Regulatory documents include important Boxed Warnings regarding the potential for rare, serious systemic events, such as cardiovascular thrombotic events (like a heart attack or stroke) and gastrointestinal adverse events (like bleeding or ulceration). Official information indicates that the risk of these systemic effects is described as potentially increasing with the duration of use and the extent of skin coverage.

Q: Does Locagel have any interactions with common vitamins or supplements?

While the official regulatory labels detail interactions with certain prescription medications, they generally state that there is not enough information to definitively confirm the safety of complementary medicines, herbal remedies, and general supplements when used with the active ingredient. Official guidance emphasizes the importance of reviewing all products used, including supplements, with a health professional.

Q: Can Locagel be used with a heating pad or ice pack?

Regulatory administration instructions state that the use of external heat or occlusive dressings (such as tight bandages) on the treated area is not permitted. There are no specific instructions in regulatory documentation regarding the use of ice packs on the treated skin area.

Q: What happens if I forget to use Locagel when I should?

In the event of a missed application, official patient instructions typically describe the procedure as continuing with the next scheduled dose at the usual time. They are generally advised not to double the dose to compensate for the missed one.

Q: Is it necessary to wash the application area before using Locagel?

Official administration instructions for Locagel require that the skin on the area to be treated must be clean and dry before the product is applied. This is necessary for adherence to the administration procedure.

Q: Can I apply makeup or other skin products over Locagel?

Regulatory instructions state that the treated area must be completely dry before any other topical substances, including cosmetics, sunscreens, or other medications, are applied.

Q: Do studies suggest any long-term effects from using Locagel repeatedly?

Official guidelines specify that the product should be used for the shortest duration necessary and with the lowest effective dosage consistent with individual treatment goals. Regulatory warnings indicate that the risk of rare, serious systemic adverse events increases with the total duration of use.

Q: Is Locagel the same as other similar products I see?

Locagel is classified as a specific topical Nonsteroidal Anti-Inflammatory Drug (NSAID) that contains the active ingredient diclofenac. While other products may also contain diclofenac, regulatory documents emphasize that the specific formulation (such as a gel vs. a solution) and strength are unique to the particular approved product.

Q: Is Locagel only for temporary relief, or can it be used long term?

Official regulatory guidance emphasizes using the product for the shortest duration necessary to achieve relief, and typically advises not exceeding 21 days unless directed by a health professional. The overarching guidance is to use the lowest effective dosage for the shortest duration.

Q: Is Locagel available over-the-counter?

The regulatory status of topical diclofenac formulations is variable depending on the country, the strength, and the intended use. Some formulations of the product are officially classified for prescription use, while others have been approved for over-the-counter (OTC) use in certain regions.

Q: Are there different strengths or formulations of Locagel available?

The official documentation confirms Locagel is a specific topical gel formulation containing diclofenac diethylamine. Other approved topical diclofenac products may be available in different strengths (such as 1% or 3%) or different formulations (such as a patch or a solution).

Q: Why might a doctor prescribe Locagel instead of another treatment?

Locagel is an NSAID specifically formulated for topical use. Regulatory documents indicate that this delivery method allows for a localized anti-inflammatory and analgesic effect with a substantially lower systemic absorption compared to oral NSAID forms. This is the primary feature noted in the regulatory profile.

Q: Can Locagel be used on sensitive skin areas?

The most common documented side effects of Locagel are local skin reactions at the application site, which include dermatitis and rash. Official instructions state that application on broken skin, open wounds, mucous membranes, or near the eyes is not permitted.

Q: Are there any known issues with applying Locagel before going into the sun?

Official documentation specifies that the treated area must be protected from natural and artificial sunlight. Regulatory warnings indicate that sun exposure may lead to a severe skin reaction known as photosensitivity or photoallergy.

Q: What are the risks if Locagel is accidentally swallowed?

Due to the low systemic absorption of the topical formulation, the risk of accidental ingestion is generally described as less severe than with oral NSAIDs. If a large amount is swallowed, the potential symptoms of overdose are consistent with systemic NSAID exposure and may include drowsiness, nausea, or stomach pain.

Q: What is the difference between Locagel and a cream?

Locagel is officially classified as a topical solution or a gel/emulgel. This specific pharmaceutical form is distinct from a cream or ointment in its physical base and composition, which is designed to optimize how the active ingredient is delivered through the skin.

Q: Are there restrictions on driving or operating machinery while using Locagel?

Although systemic absorption is low, rare systemic effects of the active ingredient may include effects on the central nervous system such as dizziness or drowsiness. Official documentation indicates that driving or operating machinery should be avoided if individuals experience these effects.

Q: Can older adults use Locagel without special precautions?

Official warnings state that older adults are generally described as being at a greater risk for serious systemic adverse events (e.g., gastrointestinal and cardiovascular events) when using any NSAID. Closer monitoring is often recommended, particularly if they are also using blood pressure medications or have underlying kidney conditions.

Q: Is there a maximum amount of time Locagel is recommended to be used for?

While the specific maximum duration can vary by formulation, the overarching regulatory guidance is to use the product for the shortest duration necessary and to not exceed 21 days unless directed by a health professional. Duration of use should be consistent with the approved indication.

Q: Why do some people report feeling a cooling sensation when using Locagel?

The gel formulation of Locagel typically utilizes an aqueous or hydro-alcoholic base. The cooling sensation that some people report is related to the physical composition of the gel and the rapid evaporation of the water or alcohol component upon application to the skin.

Q: Are there any known drug-herb interactions with Locagel?

Regulatory sources generally advise that there is not enough official information on the safety profile of herbal remedies and supplements when combined with the active ingredient in Locagel. Official guidance emphasizes the importance of reviewing all remedies used with a health professional.

Q: Does using more Locagel make it work faster?

Official administration instructions detail a fixed, measured dose that must not be exceeded. Regulatory warnings state that using more than the directed amount is explicitly linked to an increased risk of systemic adverse events.

Q: Can Locagel be used for conditions not specifically listed in its main uses?

The product is officially approved only for the specific conditions listed in the 'Indications and Usage' section of the regulatory label (e.g., localized pain, osteoarthritis). Use for conditions not listed in the official documentation is not supported by the regulatory documents.

Q: Is there a potential for abuse or dependence with Locagel?

Locagel's active ingredient, diclofenac, is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). It is not classified as a controlled substance and has no known potential for abuse or physical dependence according to regulatory bodies.

Q: Does my body absorb much of Locagel through the skin?

Clinical data in regulatory documents confirm that the systemic absorption (the amount entering the bloodstream) of the active ingredient through the skin is substantially lower than that observed with oral formulations. This low absorption is a key feature that allows for localized action.

Q: Are there any environmental factors (like heat or cold) that affect how Locagel works?

Patients are specifically instructed to avoid applying external heat to the treated area. Furthermore, the product must be stored at a controlled room temperature to maintain its stability and effectiveness, suggesting environmental temperature may be a factor.

Q: Is the purpose of Locagel similar across all international regulatory bodies?

Across major international regulatory bodies, the product's fundamental purpose is consistently described as the localized relief of pain and inflammation. The specific approved conditions for use are similar across regions, predominantly relating to musculoskeletal conditions like soft tissue injury or localized arthritis pain.

How should Locagel be stored and disposed of?

Storage Requirements

Official regulatory documents require Locagel (Diclofenac Diethylamine gel) to be stored at Controlled Room Temperature, typically between 20^circC and 25^circC (68^circF to 77^circF), and below 30^circC for most formulations. It is strictly required to avoid freezing the product. The gel must be kept in its original container and be tightly closed to protect it from light and moisture.

Stability and Child Safety

For stability, the regulatory shelf-life after first opening varies by formulation, with some requiring disposal after 3 months of use. Mandatory child-safety rules state to keep the medicine out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired Locagel must be conducted in accordance with local requirements. Due to the documented risk to the aquatic environment, the product must not be discharged into drains, water courses, or onto the ground.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Locagel found in:

A-Z Index: